Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome

European Journal of Haematology

Volumn 73, Issue 6, 2004, Pages 437-440

  Bladt, Vibeke ^a   Steengaard Pedersen, K ^a   Poulsen, L H ^a   Petersen, O B ^a   Laursen, B ^b   D'Amore, F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antiphospholipid syndrome; Immunothrombocytopenia; Puerperium

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GENE PRODUCT; IMMUNOGLOBULIN G; LOW MOLECULAR WEIGHT HEPARIN; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING DISORDER; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EPISTAXIS; FEMALE; GENE MUTATION; HELLP SYNDROME; HETEROZYGOSITY; HUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; SKIN BLEEDING; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VAGINA BLEEDING;

ABORTION, HABITUAL; ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; AZATHIOPRINE; CESAREAN SECTION; DIAGNOSIS, DIFFERENTIAL; FACTOR V; FEMALE; HEMORRHAGIC DISORDERS; HEPARIN, LOW-MOLECULAR-WEIGHT; HETEROZYGOTE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POSTOPERATIVE COMPLICATIONS; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PUERPERAL DISORDERS; THROMBOCYTOPENIA; THROMBOPHLEBITIS; THROMBOSIS;

EID: 9444231138     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00319.x     Document Type: Article

References (17)

1. GALLI M, BARBUI T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol 2003;16:211-225.
2. LEVINE JS, BRANCH DW, RAUCH J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
3. CERVERA R, PIETTE JC, FONT J, et al. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027.
4. BICK RL. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management. Hematol Oncol Clin North Am 2000;14:999-1044. Review.
5. SEBIRE NJ, BACKOS M, EL GADDAL S, GOLDIN RD, REGAN L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003;101:258-263.
6. HOCHBERG MC. Updating the American College of Rheumatology Revised Criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. MAYMON R, SEHMI IK, HERMAN A, JONES RG, SHERMAN D, CUCKLE H. Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. Prenat Diagn 2000;20:12-16.
8. JANSSON R, KARLSSON FA, LINDE A, SJOBERG O. Postpartum activation of autoimmunity. transient increase of total IgG levels in normal women and in women with autoimmune thyroiditis. Clin Exp Immunol 1987;70:68-73.
9. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, DERKSEN RH, MACHIN SJ, BARQUINERO J, OUTT HH, HARRIS EN, VILARDELL-TORRES M, HUGHES GR. The 'primary' antiphospholipid syndrome; clinical and serological features. Medicine 1989;68:366-374.
10. SETTY YN, KOMATIREDDY GR. Antiphospholipid antibodies in systemic lupus erytematosus and the antiphospholipid syndrome. Front Biosci 2001;6:207-212. Review.
11. ASHERSON RA, CERVERA R, DE GROOT PG, ECKAN D, BOFFA MC, PIETTE JC, KHAMASHTA MA, SHOENFELD Y. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome. International consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-534.
12. ASHERSON RA, CERVERA R. Catastrophic antiphospholipid syndrome. Curr Rheumatol Rep 2003;5:395-400.
13. GALLI M, LUCIANI D, BERTOLINI G, BARBUI T. Lupusanticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of literature. Blood 2003;101: 1827-1832.
14. HUDSON M, HERR AL, RAUCH J, NEVILLE C, CHANG E, IBRAHIM R, SEGUIN C, KASSIS J, BUSQUE L, FORTIN PR. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol 2003;30:2385-2391.
15. SHAMSEDDINE A, CHEHAL A, USTA I, SALEM Z, EL-SAGHIR N, TAHER A. Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review. J Clin Apheresis 2004;19:5-10.
16. WALENGA JM, JESKE WP, PRECHEL MM, BACHER P, BAKHOS M. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Semin Thromb Hemost 2004;30(Suppl. 1): 69-80.
17. DINOUR D, YINNON AM, SLOTKI IN, ROSENMANN E, BREZIS M. Postpartum renal failure in systemic lupus erythematosus. Clin Nephrol 1990;34:152-156.